XML 124 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2

Segment Information (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Operations by Reportable Segment

Approximate information concerning the Company’s operations by reportable segment for the six and three months ended June 30, 2022 and 2021 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein:

Schedule of Operations by Reportable Segment

Three Months Ended June 30, 2022		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	3,599,000			$	831,000			$	6,111,000			$	94,000			$	823,000			$	313,000			$	11,771,000
Depreciation and amortization			177,000				-				159,000				278,000				2,530,000				14,000				3,158,000
Interest expense			34,000				-				(321,000	)			-				408,000				-				121,000
Interest income			1,000				-				2,000				91,000				34,000				11,000				139,000
Amortized debt discount			-				-				-				-				-				-				-
Stock based compensation			-				-				-				-				-				-				-
Net income (loss) from continuing operations			365,000				25,000				892,000				(673,000	)			(3,332,000	)			(2,687,000	)			(5,410,000	)
Capital expenditures			254,000				-				12,000				-				2,000				1,000				269,000
Identifiable assets			26,688,000				52,416,000				52,267,000				56,524,000				85,436,000				9,617,000				282,948,000

Three Months Ended June 30,2021		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	3,376,000			$	-			$	809,000			$	-			$	-			$	-			$	4,185,000
Depreciation and amortization			191,000				-				274,000				278,000				-				74,000				817,000
Interest expense			19,000				-				2,000				1,000				67,000				17,000				106,000
Stock based compensation			1,000				-				-				-				-				(31,000	)			(30,000	)
Impairment of goodwill			-				-				-												-				-
Net income (loss) from continuing operations			65,000				-				(5,985,000	)			(610,000	)			(173,000	)			(4,022,000	)			(10,725,000	)
Capital expenditures			1,202,000				-				-				-				6,565,000				(57,000	)			7,710,000
Identifiable assets			29,463,000				-				44,772,000				53,717,000				10,939,000				52,270,000				191,161,000

Six Months Ended June 30, 2022		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	7,168,000			$	960,000			$	13,043,000			$	94,000			$	2,497,000			$	302,000			$	24,064,000
Depreciation and amortization			357,000				-				208,000				556,000				5,216,000				88,000				6,425,000
Interest expense			58,000				-				-				-				1,441,000				-				1,499,000
Stock based compensation			1,000				-				-				-				-				3,000				4,000
Income tax benefit			-				-				-				-				-				-				-
Net income (loss) from continuing operations			323,000				207,000				(3,472,000	)			(1,289,000	)			(5,838,000	)			(4,292,000	)			(14,361,000	)
Capital expenditures			943,000				-				14,000				-				15,000				4,000				976,000
Identifiable assets			26,688,000				52,416,000				52,267,000				56,524,000				85,436,000				9,617,000				282,948,000

Six Months Ended June 30,2021		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	7,237,000			$	-			$	1,416,000			$	-			$	-			$	-			$	8,653,000
Depreciation and amortization			307,000				-				319,000				556,000				-				153,000				1,335,000
Interest expense			39,000				-				2,000				1,000				67,000				17,000				126,000
Stock based compensation			1,000				-				-				-				-				(16,000	)			(15,000	)
Income tax benefit			-				-				-				-				-				2,691,000				2,691,000
Net income (loss) from continuing operations			283,000				-				(7,785,000	)			(1,308,000	)			(231,000	)			(5,746,000	)			(14,787,000	)
Capital expenditures			1,202,000				-				6,000				-				6,565,000				55,000				7,828,000
Identifiable assets			29,463,000				-				44,772,000				53,717,000				10,939,000				52,270,000				191,161,000

Schedule of Disaggregation of Revenue

The following tables disaggregate our business segment revenues by major source:

Schedule of Disaggregation of Revenue

Printed Products Revenue Information:

Six months ended June 30, 2022
Packaging Printing and Fabrication		$	7,468,000
Commercial and Security Printing			149,000
Total Printed Products		$	7,617,000

Six months ended June 30, 2021
Packaging Printing and Fabrication		$	7,056,000
Commercial and Security Printing			181,000
Total Printed Products		$	7,237,000

Direct Marketing

Six months ended June 30, 2022
Direct Marketing Internet Sales		$	13,002,000
Total Direct Marketing		$	13,002,000

Six months ended June 30, 2021
Direct Marketing Internet Sales		$	1,416,000
Total Direct Marketing		$	1,416,000

Rental Income

Six months ended June 30, 2022
Rental income		$	3,171,000
Total Rental Income		$	3,171,000

Six months ended June 30, 2021
Rental income		$	-
Total Rental Income		$	-

Net Investment Income

Three months ended March 31, 2022
Net investment income		$	274,000
Total Management fee income		$	274,000

Three months ended March 31, 2021
Management fee income		$	-
Total Management fee income		$	-

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration